跳至主要内容
临床试验/JPRN-UMIN000027941
JPRN-UMIN000027941招募中未知

Exploratory research on efficacy and safety of transarterial chemo-embolization with warmed miriplatin for unresectable hepatocellular carcinoma - efficacy and safety of TACE with warmed miriplatin for unresectable HCC

The University of Tokyo0 个研究点目标入组 30 人开始时间: 2017年6月28日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 85years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) severly impaired liver function (Child-Pugh C) 2) jaundice with T-bil >=3mg/dL 3) severely impaired renal function (eGFR < 30 mL/min/1.73m2) 4) past history with allergy or severe adverse events after TACE 5) marked history of hypersensitivity to miriplatin, other platinum-containing drugs or iodine-containing drugs 6) uncontrolled severe thyroid disorder 7) pregnant, lactating 8) dementia with difficuty conducting TACE 9) patients judged inadequate by investigators

研究者

相似试验

Exploratory research on efficacy and safety of... | 临床试验